Obsidian Therapeutics, Inc. (OBX)
Data as of , from SEC Form 4 filings.
See up to 3 months of OBX. The 7-day demo opens the 1M and 3M ranges and puts OBX on your watchlist.
Start 7-day demoLatest OBX insider trades
Robert W. Ross - DirectorGrant or award37,653 sh- Matthew Norkunas - DirectorGrant or award
About Obsidian Therapeutics, Inc. (OBX)
Obsidian Therapeutics, Inc. is an SEC registrant, filing under CIK 0002130606, classified as pharmaceutical preparations. We track it alongside the rest of the Health Care sector. Its registration statement was declared effective on 2 July 2026, which clears it to sell shares but does not fix a trading date.
OBX Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 6 | 225,918 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
OBX insider transactions (Form 4)
66 Form 4 filings on record, the earliest from Aug 5, 2026, newest first.
| Traded | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Robert W. Ross - Director | Grant or award | Stock Option (Right to Buy) | 37,653 | $0.00 | - | |
| Matthew Norkunas - Director | Grant or award | Stock Option (Right to Buy) | 37,653 | $0.00 | - | |
| Madan Jagasia - Officer | Grant or award | Stock Option (Right to Buy) | 37,653 | $0.00 | - | |
| Peter Barrett - Director | Grant or award | Stock Option (Right to Buy) | 37,653 | $0.00 | - | |
| Heidi Hagen - Director | Grant or award | Stock Option (Right to Buy) | 37,653 | $0.00 | - | |
 Maria Fardis - Director | Grant or award | Stock Option (Right to Buy) | 37,653 | $0.00 | - |
OBX insider trading FAQ
What is the latest insider trade for OBX?
Obsidian Therapeutics, Inc. (OBX) had 6 insider filings in the last 90 days, with the most recent on 5 August 2026. The full record for OBX runs to 6 Form 4 filings, the earliest from 5 August 2026. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying OBX stock?
No insider purchases of OBX were filed in the last 90 days.
How many insiders are selling OBX stock?
No insider sales of OBX were filed in the last 90 days.
Where can I see OBX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects OBX Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
6The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Robert W. Ross view on EDGAR
- - Matthew Norkunas view on EDGAR
- - Madan Jagasia view on EDGAR
- - Peter Barrett view on EDGAR
- - Heidi Hagen view on EDGAR
- - Maria Fardis view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where OBX's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow OBX with a 7-day demo
- OBX on your watchlist
- Every OBX Form 4 filing on record
- Up to 3 months of OBX price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
